SAA proteins are found induced in patients with lung cancer, sarcoidosis, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease [101], so they may be used as a potential clinical biomarker of different lung diseases. Here, SAA2 is linked to lung carcinoma.